Key facts
- BALYASNY ASSET MANAGEMENT L.P. filed SCHEDULE 13G/A for Opus Genetics Inc. Common Stock, par value $0.0001 per share (IRD).
- Disclosed ownership: 7.2%.
- Date of event: 31 Mar 2026.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Balyasny Asset Management L.P. | 7.2% | 5,110,373 | 5,110,373 | 0 | /s/ Scott Schroeder | Scott Schroeder / Authorized Signatory | |
| BAM GP LLC | 7.2% | 5,110,373 | 5,110,373 | 0 | /s/ Scott Schroeder | Scott Schroeder / Authorized Signatory | |
| Balyasny Asset Management Holdings LP | 7.2% | 5,110,373 | 5,110,373 | 0 | /s/ Scott Schroeder | Scott Schroeder / Authorized Signatory | |
| Dames GP LLC | 7.2% | 5,110,373 | 5,110,373 | 0 | /s/ Scott Schroeder | Scott Schroeder / Authorized Signatory | |
| Dmitry Balyasny | 7.2% | 5,110,373 | 5,110,373 | 0 | /s/ Dmitry Balyasny | Dmitry Balyasny / Self |
CIK / CUSIP context first